Julie McCrossin: Model LINACs Patient and Family Education.
Julie McCrossin, Broadcaster, MC, and Cancer Advocate, made the following post on LinkedIn:
“Model LINACs Patient and Family Education.
Since I was successfully treated for Stage 4 Throat Cancer ten years ago, I have advocated for the use of Model LINACs (Radiation Therapy Machines) to show patients & their families what the treatment looks like. I got a traumatic shock in the first of my 33 sessions because I hadn’t seen what was involved & I wasn’t psychologically prepared.
Families need to see the model too because most radiation patients are outpatients. Family members or carers need to understand what is involved so they can support us emotionally.
Multidisciplinary cancer team members I talk to about this all agree it is a great idea. But very few radiation teams actually do it.
Here are my thoughts on what would make the use of Model LINACs for patient & family education successful.
1. Simplicity of model.
2. Ease of construction.
3. Robustness of model.
4. Reliable supply chain for additional models that your company or cancer centre controls.
5. Genuine support from champions for the concept by multidisciplinary thought leaders in your organisation at all levels of seniority.
6. The model does not need to be an exact representation of the latest LINAC. It’s purpose is to communicate visually to patients what a LINAC looks like in broad terms, where the patient lies on the machine, what the mask looks like & how it is worn while treatment is delivered, for those patients who need to wear the mask.
I’m sharing the lessons I’ve learnt so far.
A reminder that Medical Models are commonly used in other parts of health.”
For details click here.
Source: Julie McCrossin/LinkedIn
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows